Table 1.
Experimental designs for the anti-toxoplasmosis study using the mouse model

Group	T. gondii	Treatment	Active evaluation	n
I	-	Vehicle	0 ± 0.0%	5
II	1 × 105/mouse	Vehicle	99.2 ± 3.06%	5
III	1 × 105/mouse	Sulfadiazine (50 mg/kg)	84.0 ± 9.62%	5
IV	1 × 105/mouse	Meliae fructus (30 mg/kg)	82.2 ± 2.28%	5